Ascentage Pharma has executed an Exclusive Option to License Global Rights to Olverembatinib worldwide other than China and a few other areas
This clearance is a foundational step in Roche's commitment to enable routine clinical diagnosis with its digital pathology solutions
_256_384.jpg)
Cipla had earlier invested € 15 million in Ethris in 2022
Lenire is the first and only bimodal neuromodulation device to be awarded a Federal Supply Schedule (FSS) Contract from the US Government
Approval based on DUO-E trial results, which showed Imfinzi reduced the risk of disease progression or death by 58% vs. chemotherapy
Augtyro is the only FDA-approved treatment option for NTRK-positive tumors studied in both TKI-naïve and TKI-pretreated patients across solid tumors
Co-founder and previous CEO Lowry Curley becomes Chief Scientific Officer
Over 13 million US adults aged 50-59 years have a medical condition that increases their risk of severe RSV outcomes
Azilsartan Medoxomil and Chlorthalidone Tablets had annual sales of US$ 77.9 mn in the United States (IQVIA MAT March 24).
Private financing round supported by Fidelity Management & Research Company, T. Rowe Price and Durable Capital Partners
Subscribe To Our Newsletter & Stay Updated
